Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic…
この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic…
この記事を読む
Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunot…
この記事を読む
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC. Wang K et al.J Thorac Oncol. 2024 Mar;19(3):500-506…
この記事を読む
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osi…
この記事を読む
Primary Spontaneous Pneumothorax (Clinical Decisions) Smyth R et al.N Engl J Med 2024;390:666-668 症例提示30歳の男性が、急な右側胸部痛と軽度…
この記事を読む
Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non-Small Cell Lung Cancer: Real-World Eff…
この記事を読む
Rheumatoid Arthritis and Risk of Lung Cancer: A Nationwide Cohort Study. Cho MH et al.J Thorac Oncol. 2024 Feb;19(2…
この記事を読む
Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy…
この記事を読む
Surgical Resection of Benign Nodules in Lung Cancer Screening: Incidence and Features. Archer JM et al.JTO Clin Res Rep.…
この記事を読む
Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Funct…